Selected research
Industry Growth & Trends
Global Erdosteine Industry Growth and Trends Forecast to 2032
Market perspective
The global Erdosteine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Erdosteine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Erdosteine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Erdosteine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Erdosteine include Zhejiang Kangle Pharmaceutical, Shanghai Pukang Pharmaceuticals, Wuhan Yuancheng Pharmaceutical, Edmond Pharma and Alitair Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Erdosteine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Erdosteine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Erdosteine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Erdosteine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Erdosteine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Erdosteine Market by Company
Zhejiang Kangle Pharmaceutical
Shanghai Pukang Pharmaceuticals
Wuhan Yuancheng Pharmaceutical
Edmond Pharma
Alitair Pharmaceuticals
Erdosteine Segment by Type
Tablets
Capsules
Erdosteine Segment by Application
Bronchitis
Nasopharyngitis
Others
Erdosteine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erdosteine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erdosteine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erdosteine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erdosteine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Erdosteine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Bronchitis
- Nasopharyngitis
- Others
Companies covered
- Zhejiang Kangle Pharmaceutical
- Shanghai Pukang Pharmaceuticals
- Wuhan Yuancheng Pharmaceutical
- Edmond Pharma
- Alitair Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Erdosteine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Erdosteine Sales Estimates and Forecasts (2021-2032)
- 1.3 Erdosteine Market by Type
- 1.3.1 Tablets
- 1.3.2 Capsules
- 1.4 Global Erdosteine Market Size by Type
- 1.4.1 Global Erdosteine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Erdosteine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Erdosteine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Erdosteine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Erdosteine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Erdosteine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Erdosteine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Erdosteine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Erdosteine Industry Trends
- 2.2 Erdosteine Industry Drivers
- 2.3 Erdosteine Industry Opportunities and Challenges
- 2.4 Erdosteine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Erdosteine Revenue (2021-2026)
- 3.2 Global Top Players by Erdosteine Sales (2021-2026)
- 3.3 Global Top Players by Erdosteine Price (2021-2026)
- 3.4 Global Erdosteine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Erdosteine Major Company Production Sites & Headquarters
- 3.6 Global Erdosteine Company, Product Type & Application
- 3.7 Global Erdosteine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Erdosteine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Erdosteine Players Market Share by Revenue in 2025
- 3.8.3 2025 Erdosteine Tier 1, Tier 2, and Tier 3
4 Erdosteine Regional Status and Outlook
- 4.1 Global Erdosteine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Erdosteine Historic Market Size by Region
- 4.2.1 Global Erdosteine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Erdosteine Sales in Value by Region (2021-2026)
- 4.2.3 Global Erdosteine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Erdosteine Forecasted Market Size by Region
- 4.3.1 Global Erdosteine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Erdosteine Sales in Value by Region (2027-2032)
- 4.3.3 Global Erdosteine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Erdosteine by Application
- 5.1 Erdosteine Market by Application
- 5.1.1 Bronchitis
- 5.1.2 Nasopharyngitis
- 5.1.3 Others
- 5.2 Global Erdosteine Market Size by Application
- 5.2.1 Global Erdosteine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Erdosteine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Erdosteine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Erdosteine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Erdosteine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Erdosteine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Erdosteine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Erdosteine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhejiang Kangle Pharmaceutical
- 6.1.1 Zhejiang Kangle Pharmaceutical Company Information
- 6.1.2 Zhejiang Kangle Pharmaceutical Business Overview
- 6.1.3 Zhejiang Kangle Pharmaceutical Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhejiang Kangle Pharmaceutical Erdosteine Product Portfolio
- 6.1.5 Zhejiang Kangle Pharmaceutical Recent Developments
- 6.2 Shanghai Pukang Pharmaceuticals
- 6.2.1 Shanghai Pukang Pharmaceuticals Company Information
- 6.2.2 Shanghai Pukang Pharmaceuticals Business Overview
- 6.2.3 Shanghai Pukang Pharmaceuticals Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanghai Pukang Pharmaceuticals Erdosteine Product Portfolio
- 6.2.5 Shanghai Pukang Pharmaceuticals Recent Developments
- 6.3 Wuhan Yuancheng Pharmaceutical
- 6.3.1 Wuhan Yuancheng Pharmaceutical Company Information
- 6.3.2 Wuhan Yuancheng Pharmaceutical Business Overview
- 6.3.3 Wuhan Yuancheng Pharmaceutical Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Wuhan Yuancheng Pharmaceutical Erdosteine Product Portfolio
- 6.3.5 Wuhan Yuancheng Pharmaceutical Recent Developments
- 6.4 Edmond Pharma
- 6.4.1 Edmond Pharma Company Information
- 6.4.2 Edmond Pharma Business Overview
- 6.4.3 Edmond Pharma Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Edmond Pharma Erdosteine Product Portfolio
- 6.4.5 Edmond Pharma Recent Developments
- 6.5 Alitair Pharmaceuticals
- 6.5.1 Alitair Pharmaceuticals Company Information
- 6.5.2 Alitair Pharmaceuticals Business Overview
- 6.5.3 Alitair Pharmaceuticals Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Alitair Pharmaceuticals Erdosteine Product Portfolio
- 6.5.5 Alitair Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Erdosteine Sales by Country
- 7.1.1 North America Erdosteine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Erdosteine Sales by Country (2021-2026)
- 7.1.3 North America Erdosteine Sales Forecast by Country (2027-2032)
- 7.2 North America Erdosteine Market Size by Country
- 7.2.1 North America Erdosteine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Erdosteine Market Size by Country (2021-2026)
- 7.2.3 North America Erdosteine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Erdosteine Sales by Country
- 8.1.1 Europe Erdosteine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Erdosteine Sales by Country (2021-2026)
- 8.1.3 Europe Erdosteine Sales Forecast by Country (2027-2032)
- 8.2 Europe Erdosteine Market Size by Country
- 8.2.1 Europe Erdosteine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Erdosteine Market Size by Country (2021-2026)
- 8.2.3 Europe Erdosteine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Erdosteine Sales by Country
- 9.1.1 Asia-Pacific Erdosteine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Erdosteine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Erdosteine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Erdosteine Market Size by Country
- 9.2.1 Asia-Pacific Erdosteine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Erdosteine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Erdosteine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Erdosteine Sales by Country
- 10.1.1 South America Erdosteine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Erdosteine Sales by Country (2021-2026)
- 10.1.3 South America Erdosteine Sales Forecast by Country (2027-2032)
- 10.2 South America Erdosteine Market Size by Country
- 10.2.1 South America Erdosteine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Erdosteine Market Size by Country (2021-2026)
- 10.2.3 South America Erdosteine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Erdosteine Sales by Country
- 11.1.1 Middle East and Africa Erdosteine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Erdosteine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Erdosteine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Erdosteine Market Size by Country
- 11.2.1 Middle East and Africa Erdosteine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Erdosteine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Erdosteine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Erdosteine Value Chain Analysis
- 12.1.1 Erdosteine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Erdosteine Production Mode & Process
- 12.2 Erdosteine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Erdosteine Distributors
- 12.2.3 Erdosteine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst